Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Finasteride helps reduce priapism in sickle cell anemia patients.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Tamoxifen caused hair loss in a 52-year-old woman.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Breast cancer patients need strong psychological support to improve their quality of life.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Fasting may reduce chemotherapy side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The woman's hair loss was mainly due to stress and low iron levels, and her hair grew back after treatment.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Nanoparticle systems make cancer treatment less toxic.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Flaxseed lignans may reduce breast cancer risk in women.